Neural cell adhesion molecule (redirect from CD56)
(NCAM), also called CD56, is a homophilic binding glycoprotein expressed on the surface of neurons, glia and skeletal muscle. Although CD56 is often considered...
12 KB (1,445 words) - 16:30, 31 December 2023
marrow with an abnormal immunophenotype (CD38+ CD56+ CD19−) mixed in with cells of a normal phenotype (CD38+ CD56− CD19+); in MGUS, on average more than 3%...
19 KB (2,182 words) - 16:43, 21 September 2024
lymphocyte cells. NK cells can be identified by the presence of CD56 and the absence of CD3 (CD56+, CD3−). NK cells differentiate from CD127+ common innate...
75 KB (9,227 words) - 03:58, 24 August 2024
form of lymphocyte-derived cutaneous lymphoma and alternatively named CD4+CD56+ hematodermic tumor, blastic NK cell lymphoma, and agranular CD4+ NK cell...
22 KB (2,648 words) - 06:47, 21 June 2024
cells can share other features with NK cells, as well, such as CD16 and CD56 expression and granzyme production. Invariant natural killer T (iNKT) cells...
14 KB (1,648 words) - 09:58, 18 July 2023
E-cadherin, vimentin, chromogranin A, synaptophysin, SSTR2, and NTR1, but not CD56. The cells have a round, epithelial morphology, and are adherent in cell...
2 KB (240 words) - 18:23, 2 December 2022
in 95% of cases; CD4 found in 76% of cases; HLA-DR found in 71% of cases; CD56 found in 53% of cases; CD2 found in 34% of cases; CD16 found in 29% of cases;...
25 KB (2,922 words) - 14:19, 29 August 2023
polynuclear leukocytes and B cells are scant. The large granular lymphocytes (CD56 bright) are called uterine natural killer cells| (uNK cells). After ovulation...
8 KB (804 words) - 17:58, 27 September 2024
killer cells Lysis of virally infected cells and tumour cells 7% (2–13%) CD16 CD56 but not CD3 T helper cells Release cytokines and growth factors that regulate...
23 KB (2,445 words) - 18:22, 18 August 2024
"Possibility of adoptive immunotherapy with peripheral blood-derived CD3−CD56+ and CD3+CD56+ cells for inducing antihepatocellular carcinoma and antihepatitis...
59 KB (6,128 words) - 05:06, 8 July 2024
cytoplasm and occasionally on the cell surface; myeloma cells are often CD56, CD38, CD138, and CD319 positive and CD19, CD20, and CD45 negative. Flow...
131 KB (13,506 words) - 14:36, 4 September 2024
such as T-lymphocytes. As a special feature, terminally differentiated CD3+CD56+ CIK cells possess the capacity for both MHC-restricted and MHC-unrestricted...
18 KB (2,276 words) - 08:23, 3 June 2024
(NK cells, granulocytes), CD19 (B lymphocytes), CD20 (B lymphocytes), and CD56 (NK cells) in humans. Lineage markers include mitochondrial DNA (mtDNA) and...
2 KB (224 words) - 21:54, 19 July 2023
markers of neuroendocrine cells, such as chromogranin, synaptophysin, and CD56. Adenocarcinomas tend to express Napsin-A and TTF-1; squamous cell carcinomas...
90 KB (9,784 words) - 14:55, 18 September 2024
Bivatuzumab mertansine Cantuzumab mertansine Lorvotuzumab mertansine (IMGN901) for CD56 positive cancers, for example multiple myeloma DM1 can also be linked via...
6 KB (471 words) - 09:43, 12 February 2024
Lorvotuzumab mertansine (IMGN901) is an antibody-drug conjugate. It comprises the CD56-binding antibody, lorvotuzumab (huN901), with a maytansinoid cell-killing...
3 KB (180 words) - 01:31, 30 May 2023
CD45 CD46 CD47 CD48 CD49 a b c d e f CD50 51–100 CD51 CD52 CD53 CD54 CD55 CD56 CD57 CD58 CD59 CD61 CD62 E L P CD63 CD64 A B C CD66 a b c d e f CD68 CD69...
11 KB (1,311 words) - 20:50, 18 October 2022
number of molecules have been proposed as markers for this group of tumours. CD56 may be useful for distinguishing sex cord–stromal tumours from some other...
14 KB (1,434 words) - 18:07, 5 January 2024
markers. Cells may aberrantly express B-cell marker CD20 and the NK marker CD56. Monoblasts may be positive for CD34. AML-M5 is treated with intensive chemotherapy...
6 KB (605 words) - 20:46, 23 July 2024
CD45+, CD3+, CD8+ B lymphocyte CD45+, CD19+, CD20+, CD24+, CD38, CD22 Thrombocyte CD45+, CD61+ Natural killer cell CD16+, CD56+, CD3-, CD31, CD30, CD38...
14 KB (1,368 words) - 17:53, 4 September 2024
T cell (lymphoma, leukemia) (most CD3 CD4 CD8) NK cell/ (most CD56) Aggressive NK-cell leukemia Blastic NK cell lymphoma T or NK EBV (Extranodal NK-T-cell...
57 KB (7,246 words) - 00:23, 27 June 2024
T cell (lymphoma, leukemia) (most CD3 CD4 CD8) NK cell/ (most CD56) Aggressive NK-cell leukemia Blastic NK cell lymphoma T or NK EBV (Extranodal NK-T-cell...
73 KB (7,597 words) - 22:02, 28 August 2024
CD45 CD46 CD47 CD48 CD49 a b c d e f CD50 51–100 CD51 CD52 CD53 CD54 CD55 CD56 CD57 CD58 CD59 CD61 CD62 E L P CD63 CD64 A B C CD66 a b c d e f CD68 CD69...
21 KB (2,283 words) - 20:27, 28 September 2024
malignant cells express markers characteristic of NK and/or T cells (e.g. CD2, CD56, CD38), granzyme B, perforin, TIA1, and, with respect to T cells which are...
140 KB (16,977 words) - 09:07, 9 September 2024
CD45 CD46 CD47 CD48 CD49 a b c d e f CD50 51–100 CD51 CD52 CD53 CD54 CD55 CD56 CD57 CD58 CD59 CD61 CD62 E L P CD63 CD64 A B C CD66 a b c d e f CD68 CD69...
25 KB (3,052 words) - 15:34, 14 September 2024
CD45 CD46 CD47 CD48 CD49 a b c d e f CD50 51–100 CD51 CD52 CD53 CD54 CD55 CD56 CD57 CD58 CD59 CD61 CD62 E L P CD63 CD64 A B C CD66 a b c d e f CD68 CD69...
33 KB (3,930 words) - 21:04, 3 September 2024
CD45 CD46 CD47 CD48 CD49 a b c d e f CD50 51–100 CD51 CD52 CD53 CD54 CD55 CD56 CD57 CD58 CD59 CD61 CD62 E L P CD63 CD64 A B C CD66 a b c d e f CD68 CD69...
27 KB (3,084 words) - 01:44, 21 December 2023
CD45 CD46 CD47 CD48 CD49 a b c d e f CD50 51–100 CD51 CD52 CD53 CD54 CD55 CD56 CD57 CD58 CD59 CD61 CD62 E L P CD63 CD64 A B C CD66 a b c d e f CD68 CD69...
22 KB (2,834 words) - 03:10, 29 September 2024
CD45 CD46 CD47 CD48 CD49 a b c d e f CD50 51–100 CD51 CD52 CD53 CD54 CD55 CD56 CD57 CD58 CD59 CD61 CD62 E L P CD63 CD64 A B C CD66 a b c d e f CD68 CD69...
22 KB (2,581 words) - 20:03, 21 June 2024
CD45 CD46 CD47 CD48 CD49 a b c d e f CD50 51–100 CD51 CD52 CD53 CD54 CD55 CD56 CD57 CD58 CD59 CD61 CD62 E L P CD63 CD64 A B C CD66 a b c d e f CD68 CD69...
15 KB (1,716 words) - 17:02, 7 November 2023